173341-02-1

Basic information

• Product Name: 2-N-BOC-AMINOMETHYLMORPHOLINE
• Synonyms: 2-N-BOC-AMINOMETHYLMORPHOLINE ;tert-butyl (morpholin-2-ylmethyl)carbamate;tert-butyl (morpholin-2-ylmethyl)carbamate(SALTDATA: FREE);Carbamic acid,N-(2-morpholinylmethyl)-, 1,1-dimethylethyl ester;tert-butyl N-(morpholin-2-ylmethyl)carbamate
• CAS NO: 173341-02-1
• Molecular Formula: C₁₀H₂₀N₂O₃
• Molecular Weight: 216.2774
• Mol File: 173341-02-1.mol

Chemical Properties

• Boiling Point: 334 °C at 760 mmHg
• Flash Point: 155.8 °C
• Appearance: /
• Density: 1.032 g/cm³
• Vapor Pressure: 0.000131mmHg at 25°C
• Refractive Index: 1.452
• Storage Temp.: 2-8°C(protect from light)
• PKA: 12.22±0.46(Predicted)
• CAS DataBase Reference: 2-N-BOC-AMINOMETHYLMORPHOLINE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-N-BOC-AMINOMETHYLMORPHOLINE(173341-02-1)
• EPA Substance Registry System: 2-N-BOC-AMINOMETHYLMORPHOLINE(173341-02-1)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 173341-02-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Development:
2-N-BOC-Aminomethylmorpholine is used as a reactant or raw material for the synthesis of various pharmaceutical compounds. Its amine group and BOC protecting group facilitate the creation of new drug molecules, contributing to the advancement of medicinal chemistry.
Used in Organic Synthesis:
In the field of organic chemistry, 2-N-BOC-Aminomethylmorpholine is employed as a building block for the synthesis of complex organic compounds. Its unique structure allows for the formation of diverse chemical entities, expanding the scope of organic synthesis.
Used in Industrial Processes:
2-N-BOC-Aminomethylmorpholine is utilized in various industrial applications, where its chemical properties are harnessed to produce a range of products. Its versatility and reactivity make it a valuable component in the manufacturing of specialty chemicals and materials.

InChI:InChI=1/C10H20N2O3/c1-10(2,3)15-9(13)12-7-8-6-11-4-5-14-8/h8,11H,4-7H2,1-3H3,(H,12,13)

Upstream product

• 146944-34-5 (4-benzylmorpholin-2-ylmethyl)carbamic acid tert-butyl ester 
• 112913-97-0 2-(azidomethyl)-4-benzylmorpholine 
• 40987-25-5 N-benzyl-2-chloromethylmorpholine 
• 110859-47-7 (4-benzylmorpholin-2-yl)methanamine 

Downstream Products

• 558465-42-2 t-butyl {[4-[5-chloro-4-[(4-chlorophenylthio)(2,5-difluorophenyl)methyl]pyridine-2-yl]morpholine-2-yl]methyl}carbamate 
• 1034769-89-5 tert-butyl (4-(5-bromo-1-(4-methoxybenzyl)-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl)methylcarbamate 
• 1034769-80-6 tert-butyl (4-(2-(benzylamino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)morpholin-2-yl)methylcarbamate 
• 1034769-97-5 tert-butyl (4-(1-(4-methoxybenzyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl)methylcarbamate 
• 1185190-89-9 tert-butyl {4-[4-(3,5-dimethyl-phenylsulfanyl)-5-iodo-2-methyl-6-oxo-1,6-dihydropyridin-3-ylmethyl]-morpholin-2-ylmethyl}-carbamate 
• 1334713-60-8 tert-butyl N-({4-[1-(4-methylphenyl)-1H-pyrazolo[3,4-c]pyridin-3-yl]morpholin-2-yl}methyl)carbamate 
• 1427589-25-0 tert-butyl N-({4-[1-(4-chlorophenyl)-1H-pyrazolo[3,4-c]pyridin-3-yl]morpholin-2-yl}methyl)carbamate 
• 1427588-41-7 propan-2-yl N-({4-[1-(4-methylphenyl)-1H-pyrazolo[3,4-c]pyridin-3-yl]morpholin-2-yl}methyl)carbamate 
• 1427588-42-8 3-cyclopropyl-1-({4-[1-(4-methylphenyl)-1H-pyrazolo[3,4-c]pyridin-3-yl]morpholin-2-yl}methyl)urea 
• 1610505-80-0 [4-(4-trifluoromethylphenyl)morpholin-2-ylmethyl]carbamic acid tert-butyl ester 
• 1351533-45-3 tert‐butyl ((4‐(5‐(3‐cyanophenyl)‐7H‐pyrrolo[2,3‐d]pyrimidin‐4‐yl)morpholin‐2‐yl)methyl)carbamate 

Relevant articles and documents

INDAZOLE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS

The present invention relates to novel indazole compounds of the Formula (I), wherein, R1 is alkyl or cycloalkyl; (Formula II) including their stereoisomers and their pharmaceutically acceptable salts. This invention also relates to methods of making such compounds and pharmaceutical compositions comprising such compounds. The compounds of this invention are useful in the treatment of various disorders that are related to 5-Hydroxytryptamine 4 (5-HT4) receptor agonists

AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME

Disclosed is a compound having a strong affinity to serotonin-4 receptors, which is useful as an enterokinesis-promoting agent or a digestive tract function-improving agent. Specifically, disclosed is a compound represented by Formula (1) or a pharmaceutically acceptable salt thereof. Also specifically disclosed is a pharmaceutical composition containing a compound represented by Formula (1) or a pharmaceutically acceptable salt thereof. [In Formula (1), Ar represents a group represented by Formula (Ar-1) or Formula (Ar-2).]

ANTIBACTERIAL AGENTS

Naphthalene, quinoline, quinoxaline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.

NOVEL COMPOUNDS HAVING AN ANTI-BACTERIAL ACTIVITY

The present invention describes novel anti-bacterial compounds of formula (I). These compounds are, amongst others, of interest as inhibitors of DNA gyrase.

NOVEL COMPOUNDS WITH ANTIBACTERIAL ACTIVITY

The invention relates to novel antibacterial compounds of formula (I).